Cheng C, Edin NF, Lauritzen KH, Aspmodal I, Christoffersen S, Jian L, Rasmussen LJ, Pettersen EO, Xiaoqun G, Bergersen LH (2012) Alterations of monocarboxylate transporter densities during hypoxia in brain and
breast tumour cells Cell Oncol (Dordr), 35 (3), 217 - 27 PubMed 22700320
Not exact matches
Molecular characterization of the
cells that undergo
cell fate transition upon oncogenic Pik3ca expression demonstrated a profound oncogene - induced reprogramming of these newly formed
cells and identified gene expression signatures, characteristic of the different
cell fate switches, which was predictive of the cancer
cell of origin,
tumour type and clinical outcomes in women with
breast cancers.
High levels of the protein were also found in cultures of metastatic
cells from
tumours of the colon,
breast, head and neck.
Cardiff University scientists have developed a novel anti-cancer stem
cell agent capable of targeting aggressive
tumour forming
cells common to
breast, pancreas, colon and prostate cancers.
Around 15 per cent of women with
breast cancer have this form of the disease, in which
tumour cells lack the three receptors that most drugs target.
A COMPOUND that slows the proliferation of triple - negative
breast cancer
cells in lab tests could lead to the first drugs to target this aggressive type of
tumour.
Now, the researchers have discovered an alternative in a mouse model: in the case of
breast tumours with a specific defect in DNA repair, the animals can be cured using already established, cheap chemotherapy drugs, if enough DNA damage can be inflicted on the resting
tumour cells.
The time needed for
breast cancer metastases (secondary lesions caused by
cells that have escaped from the original
tumour) to develop varies between patients, and little is known about the mechanisms that govern latency (the dormant state of
cells that have already spread through the body).
Around 70 % of all cases of
breast cancer are oestrogen - receptor positive, meaning that the cancer
cells have a particular protein (known as a receptor) that responds to the female sex hormone oestrogen, enabling the
tumour to grow.
Lead author Moustafa Abdalla writes: «Almost all genomic studies of
breast cancer have focused on well - established
tumours because it is technically challenging to study the earliest mutational events occurring in human
breast epithelial
cells.»
In addition, they showed for the first time that these genes are often the same as those that are altered in
breast tumours - when a
tumour develops, the DNA within the cancer
cells themselves mutates.
Breast cancer researchers have mapped early genetic alterations in normal - looking
cells at various distances from primary
tumours to show how changes along the lining of mammary ducts can lead to disease.
«Brain metastases are a secondary brain
tumour, which means they are caused by cancer
cells that escape from primary
tumours like lung,
breast or melanoma, and travel to the brain,» said Mohini Singh, the study's primary author and a PhD candidate in biochemistry at the Michael G. DeGroote School of Medicine at McMaster.
Breast cancer
cells that spread to other parts of the body break off and leave the primary
tumour at late stages of disease development, scientists from the Wellcome Trust Sanger Institute and their collaborators have found.
The team found that most of the genetic changes in the original
breast tumour were also present in the metastatic
tumours, showing that the cancer
cells spread late in disease development.
In collaboration with Dr Gabriele Bonatz from the Augusta clinics in Bochum (Brustzentrum), Hatt's team confirmed the existence of TRPV1 in
tumour cells in nine different samples from patients suffering from
breast cancer.
When cancer
cells from eg
breast or lung
tumours invade the bones through metastasis, the bone tissue is degraded.
Using a CRISPR - dCas9 epigenetic editing tool, the researchers methylated different genes in healthy
breast cells and found that those changes were sufficient to cause the
cells to undergo «hyperproliferation» — abnormally rapid
cell division which is an early stage of
tumour initiation.
Dr Claus Jorgensen, who led the research at The Institute of Cancer Research, London, and at Cancer Research UK's Manchester Institute at the University of Manchester, said: «The next step is to figure out how to keep this receptor switched on, so that the
tumour cells can't leave the blood vessels — stopping
breast cancer spreading and making the disease easier to treat successfully.»
A new biomarker could help identify abnormal
breast cells that will develop into
tumours, according to research published in Clinical Cncer Research.
Tamoxifen prevents oestrogen from stimulating growth of
breast cancer
cells but some
tumours can eventually develop resistance to the treatment, making the drug ineffective.
Combining a cancer therapy with a second drug therapy that helps suppress
tumour blood vessels found in cancer
cells can help to significantly reduce the spread of
breast cancer
tumours while also causing cancer
cell death.
T -
cells (red, yellow, and blue) attack a
tumour in a mouse model of
breast cancer following treatment with radiation and a PD - L1 immune checkpoint inhibitor, as seen by transparent
tumour tomography.
Her expertise includes isolation of stem
cells from multiple organs as well as from solid
tumours and fluid aspirates associated with
breast and ovarian
tumours.
Anti-angiogenic agents increase
breast cacner stem
cells via the generation of
tumour hypoxia
Research has discovered that a compound in parsley could prevent the growth of specific
breast cancer
tumour cells.
The Journal of Agricultural and Food Chemistry had on its December 2006 issue a report that found the ability of red raspberries to repress the human oral and
breast, as well as colon and prostate
tumour cell lines growths when they were tested in test tubes.
Malignant lymphomas (lymph node
tumours), skin cancer (mast
cell tumours), bone cancer, and
breast cancer (mammary gland
tumours) are very common in elderly furkids.
Most cases of
breast cancer in dogs (approximately 76 percent) are adenocarcinomas, or
tumours that develop in the dog's
breast duct
cell linings.